FDAers To Address Pre-, Post-Market Drug Safety At Upcoming IoM Meeting
This article was originally published in The Pink Sheet Daily
Executive Summary
Office of Drug Safety Deputy Director Trontell will discuss the use of pharmacoepidemiology in the agency's post-approval activities.